Prev Arrow Stocks

Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Up 5.0% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Tandem Diabetes Care, Inc.?

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) offers diabetes management products. The market sentiment towards the company is positive today.

Why is Tandem Diabetes Care, Inc. going up?

TNDM stock is up 5.0% on Nov 20, 2025 15:20

  • Investor optimism regarding TNDM stock is likely due to the recent news of an investigation by the Rosen Law Firm into potential securities claims on behalf of shareholders.
  • This development may have boosted investor confidence in the company's outlook.
  • The market's reaction suggests that investors are hopeful that any concerns raised in the investigation will be resolved favorably, leading to an increase in the stock price.

TNDM Price Chart

TNDM Technical Analysis

TNDM News

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. ( NASDAQ: TNDM ) , You Are Encouraged to Contact The Rosen Law Firm About Your Rights - Tandem Diabetes Care ( NASDAQ:TNDM )

NEW YORK, Nov. 19, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. ( NASDAQ:TNDM ) resulting from allegations that Tandem Diabetes Care may have ...

https://www.benzinga.com/pressreleases/25/11/g48967225/tndm-investor-news-if-you-have-suffered-losses-in-tandem-diabetes-care-inc-nasdaq-tndm-you-are-enc

0 News Article Image TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc.  ( NASDAQ: TNDM ) , You Are Encouraged to Contact The Rosen Law Firm About Your Rights - Tandem Diabetes Care  ( NASDAQ:TNDM )

Tandem Diabetes Care, Inc. Price History

07.07.2025 - TNDM Stock was down 20.7%

  • Tandem Diabetes Care (TNDM) reported a Q2 loss of $0.78, missing the estimated $0.40, leading to a significant drop in the stock price.
  • The stock also suffered due to guidance cuts and device recalls, with adverse events and injuries linked to malfunctioning insulin pumps triggering a correction.
  • Despite the bearish movement, some analysts are optimistic about TNDM, pointing to technical chart patterns like the formation of a hammer chart and positive revisions in earnings estimates as reasons to consider it a 'buy' opportunity.

07.07.2025 - TNDM Stock was down 28.7%

  • TNDM exceeded revenue expectations but reported a loss in Q2, potentially influencing the bearish trend.
  • A hammer chart formation and positive adjustments in earnings forecasts from financial analysts hint at a possible turnaround for TNDM, suggesting a chance for investment.
  • Investor wariness following the company's recent loss may be contributing to the stock's downward movement.
  • Mixed signals from the earnings report and technical chart pattern may be causing uncertainty among investors, leading to TNDM's current downward trajectory.

31.09.2025 - TNDM Stock was down 6.9%

  • The bearish movement in TNDM's stock today may be linked to the announcement of a securities class action investigation by a law firm. Concerns among investors about potential legal implications possibly triggered a sell-off.
  • Despite anticipated outperformance in earnings estimates for the upcoming period, uncertainties related to the investigation might have outweighed any positive outlook, resulting in a negative investor sentiment.
  • The current mix of positive earnings expectations and legal concerns has generated a varied sentiment, contributing to a bearish trend for TNDM's stock today.

11.07.2025 - TNDM Stock was down 5.1%

  • TNDM stock saw a significant decline after its Q2 earnings announcement, despite surpassing revenue expectations and boosting gross margin. The drop was a result of missed earnings and reduced guidance, leading to a 20% decrease in share price.
  • Concerns about device recalls and malfunctions added to the stock's plunge, with a considerable number of adverse incidents and injuries reported. This raised apprehensions among investors regarding the quality and safety standards of the company's products.
  • Despite the bearish trend, some experts suggest that TNDM might be approaching a support level, as evidenced by a hammer chart formation. Moreover, the consensus among financial analysts in increasing earnings projections could hint at a buying opportunity for investors interested in the company's long-term potential.

10.09.2025 - TNDM Stock was down 5.2%

  • A securities class action investigation could have raised concerns among investors, leading to a sell-off of TNDM shares.
  • Investor uncertainty regarding the potential outcomes of the investigation might have contributed to the bearish movement in TNDM stock.
  • The negative sentiment surrounding the company due to the ongoing legal scrutiny could have overshadowed any positive developments, impacting the stock price negatively.

04.10.2025 - TNDM Stock was up 5.2%

  • The bullish movement in TNDM stock today could be attributed to the anticipation of beating earnings estimates in the upcoming report.
  • The news of a securities class action investigation might have initially caused some uncertainty in the market, but investors seem to have focused more on the positive expectations for the earnings report.
  • Investors may be optimistic about Tandem Diabetes Care's potential for strong financial performance, leading to increased buying interest and driving the stock price higher.
  • Overall, the market movement reflects a mix of short-term concerns regarding the investigation and long-term confidence in the company's earnings potential, resulting in a bullish sentiment for TNDM stock.

31.06.2025 - TNDM Stock was down 5.0%

  • The bearish movement in TNDM stock today could be due to profit-taking by investors who were anticipating a positive earnings report.
  • Despite expectations of beating earnings estimates, market conditions or external factors might have influenced the stock's downward movement.
  • Investors may have reacted negatively to any unexpected news or developments within the company that were not captured in the earnings expectations.
  • It's possible that market sentiment shifted, leading to a sell-off in TNDM shares despite the positive outlook for earnings.

17.08.2025 - TNDM Stock was down 2.7%

  • An investigation into potential securities claims on behalf of Tandem Diabetes Care shareholders may have raised concerns and uncertainty among investors, contributing to a bearish movement in the stock.
  • An endorsement of Tandem Diabetes Care as a speculative stock for younger investors could have added volatility to the stock, attracting both buyers and sellers and contributing to the bearish trend.
  • A contrasting recommendation to buy other stocks like Cintas (NASDAQ: CTAS) and Intuitive Surgical (NASDAQ: ISRG) might have diverted attention and capital away from Tandem Diabetes Care, impacting its stock performance negatively.

06.07.2025 - TNDM Stock was down 5.0%

  • Despite recent losses, TNDM seems to have found support indicated by a hammer chart pattern, suggesting a potential reversal in the stock's movement.
  • Wall Street analysts are showing strong agreement in revising earnings estimates higher for TNDM, indicating confidence in the stock's potential.
  • The bullish sentiment from analysts combined with the technical chart pattern could be signaling a buying opportunity for investors looking to capitalize on the potential turnaround in TNDM's stock price.

20.10.2025 - TNDM Stock was up 5.0%

  • Investor optimism regarding TNDM stock is likely due to the recent news of an investigation by the Rosen Law Firm into potential securities claims on behalf of shareholders.
  • This development may have boosted investor confidence in the company's outlook.
  • The market's reaction suggests that investors are hopeful that any concerns raised in the investigation will be resolved favorably, leading to an increase in the stock price.

22.06.2025 - TNDM Stock was up 5.2%

  • TNDM observed a noteworthy upward movement today, potentially influenced by investors interpreting the recent selling pressure as a buying opportunity.
  • The technical analysis indicating TNDM being in oversold territory might have attracted value investors on the lookout for a possible stock price recovery.
  • The consensus among financial analysts raising earnings estimates for TNDM might have also played a role in fostering positive sentiment, hinting at a potential uptick in the stock's performance.
  • In summary, the amalgamation of technical indicators and analyst outlook may have been key drivers behind the positive movement in TNDM today, as investors aimed to benefit from what they viewed as an undervalued stock.

01.09.2025 - TNDM Stock was up 7.7%

  • Initial uncertainty and bearish sentiment among investors may have been influenced by an ongoing securities fraud investigation.
  • If the investigation results do not substantially impact the company, investors may become more confident in Tandem's future prospects, potentially contributing to the bullish movement.
  • Market participants seem to view the news positively, indicating that Tandem's financial health and operations may not be significantly impacted by the investigation, resulting in the stock price rise.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.